Form 8-K - Current report:
SEC Accession No. 0001558370-24-013616
Filing Date
2024-10-24
Accepted
2024-10-24 16:05:26
Documents
14
Period of Report
2024-10-23
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K pmn-20241023x8k.htm   iXBRL 8-K 46571
  Complete submission text file 0001558370-24-013616.txt   179976

Data Files

Seq Description Document Type Size
2 EX-101.SCH pmn-20241023.xsd EX-101.SCH 4050
3 EX-101.DEF pmn-20241023_def.xml EX-101.DEF 2874
4 EX-101.LAB pmn-20241023_lab.xml EX-101.LAB 17909
5 EX-101.PRE pmn-20241023_pre.xml EX-101.PRE 11840
16 EXTRACTED XBRL INSTANCE DOCUMENT pmn-20241023x8k_htm.xml XML 5094
Mailing Address SUITE 200, 1920 YONGE STREET TORONTO A6 M4S 3E2
Business Address SUITE 200, 1920 YONGE STREET TORONTO A6 M4S 3E2 416-847-6898
ProMIS Neurosciences Inc. (Filer) CIK: 0001374339 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41429 | Film No.: 241392634
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)